View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
Dana-Farber/Brigham and Women's Cancer Center has been named the best for cancer care in New England for the 15th straight year and fourth overall in the country by U.S. News & World Report.
Clinicians at Dana-Farber/Brigham and Women'’s Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
Dana-Farber's David Weinstock, MD, and colleagues report that a novel compound stops B-cell acute lymphoblastic leukemia tumor cell growth in pre-clinical studies; approach may be effective in other cancers as well.
More than two-thirds of adolescents and young adults dying of cancer utilized one or more aggressive interventions in the last month of life, according to a retrospective study published in JAMA Oncology. The findings suggest the need for more research into whether patients have been adequately supported to contemplate their end-of-life options or whether the pattern reflects their well-considered wishes.
The Department of Cancer Immunology and AIDS at Dana-Farber is changing its name to the Department of Cancer Immunology and Virology.
Dr. Deborah Schrag commented on rising costs of cancer drugs and the problems it presents to patients who have exhausted all other drug options.
Dana-Farber/Brigham and Women’s Cancer Center has been named the best for cancer care in New England for the 15th straight year and fourth overall in the country by U.S. News & World Report.
Dorothy Puhy, executive vice president and chief operating
officer at Dana-Farber, was featured for her role at the Institute.
Dr. Jennifer Mack led a first of its kind study that examines end-of-life care for people ages 15
Dr. Harold Burstein commented on a study that found regular mammogram screening for breast cancer might be causing "widespread overdiagnosis," with some women treated for tumors that would not have caused sickness or death.
Dr. Judy Garber led a study that sought to determine which breast cancer patient populations should be screened for abnormalities and how best to integrate that information into treatment protocols.
Lisa Scherber, director of Patient and Family Programs at
the Jimmy Fund Clinic, was featured for her work at Dana-Farber for the past 23
Gentle Hatha Yoga
10:00 AM - 10:45 AM
Smith Building, Room 330
This gentle Hatha Yoga class is open to patients, families and friends
that have been newly diagnosed with cancer, receiving treatment, or in
remission. Instructor, Ann Marie Turo will guide you in gentle stretches and
breathing techniques that will calm you and leave you feeling refreshed and
relaxed. Classes are complimentary and yoga mats are provided. Please contact
the Zakim Center to register at 617-632-3322 or Zakim_Center@dfci.havard.edu.
11:00 AM - 12:00 PM
This one-hour class fuses the
practices of Hatha Yoga and Pilates and is open to patients who have been newly
diagnosed with cancer, and receiving treatment, or are in remission. This class
will work on building strength, endurance, and flexibility, while toning the
deep core muscles. Yoga mats will be provided, or you may bring your own. Family, friends and staff are welcome. Please contact the Zakim Center to register at
617-632-3322 or Zakim_Center@dfci.havard.edu.
in active treatment will need medical clearance from their physician prior to
Level I-Level II Hatha Yoga
12:15 PM - 1:00 PM
level 1 - level 2 class takes it up a notch and challenges you to the core.
Learn asanas, pranayamas and a variety of yoga sequences that will challenge
your body both mentally and physically. Return to your activities of daily
living feeling energized and refreshed. Instructor: Ann Marie Turo. Family, friends and staff are welcome. Yoga
mats are provided, or feel free to bring your own. Please contact the Zakim
Center to register at 617-632-3322 or Zakim_Center@dfci.harvard.edu.
Patients in active
treatment will need medical clearance from their physician prior to
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: